» Articles » PMID: 34009230

Hollow PtCo Alloy Nanospheres As a High- and Oxygen Generating Nanozyme for Radiotherapy Enhancement in Non-small Cell Lung Cancer

Overview
Journal J Mater Chem B
Date 2021 May 19
PMID 34009230
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Radiotherapy, as well as chemotherapy and surgery, occupies an essential position in tumor treatment. Nonetheless, insufficient radiation deposition and hypoxia-related radioresistance of cancer cells still are serious challenges in radiotherapy. Herein, we proposed a hollow PtCo nanosphere (PtCo NS)-based novel radiosensitizer with three advantages to sensitize tumor radiotherapy: (i) the high-Z element Pt ensured higher radiation absorption to cause more DNA damage, (ii) the platinum (Pt) and cobalt (Co) elements exhibited a dual catalase-like enzymatic activity to convert endogenic H2O2 to O2 efficiently, and (iii) the unique hollow nature of the PtCo NS provided a large specific surface area, which could amplify the catalytic reaction of H2O2 to induce reactive oxygen species and cancer cell apoptosis upon combination with radiation. Both in vivo and in vitro studies showed that the hollow PtCo NS could significantly inhibit tumor growth, simultaneously relieving tumor hypoxia with good biocompatibility and biosafety. This work presents a simple but multifunctional radiosensitizer with a unique hollow structure for radiotherapy enhancement.

Citing Articles

Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer.

Zhao L, Li M, Shen C, Luo Y, Hou X, Qi Y Research (Wash D C). 2024; 7:0429.

PMID: 39045421 PMC: 11265788. DOI: 10.34133/research.0429.


Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.

Fakhri S, Moradi S, Faraji F, Farhadi T, Hesami O, Iranpanah A Cancer Metastasis Rev. 2023; 42(3):959-1020.

PMID: 37505336 DOI: 10.1007/s10555-023-10119-w.


Smart Nanozymes for Cancer Therapy: The Next Frontier in Oncology.

P N N, Mehla S, Begum A, Chaturvedi H, Ojha R, Hartinger C Adv Healthc Mater. 2023; 12(25):e2300768.

PMID: 37392379 PMC: 11481082. DOI: 10.1002/adhm.202300768.


Oxygen switches: Refueling for cancer radiotherapy.

Li X, Wang H, Li Z, Tao F, Wu J, Guan W Front Oncol. 2023; 12:1085432.

PMID: 36873299 PMC: 9978393. DOI: 10.3389/fonc.2022.1085432.


Multifunctional nanoparticle for cancer therapy.

Gao Y, Wang K, Zhang J, Duan X, Sun Q, Men K MedComm (2020). 2023; 4(1):e187.

PMID: 36654533 PMC: 9834710. DOI: 10.1002/mco2.187.